Europe Respiratory Care Devices Market to Cross US$ 12.97 Billion by 2033: Growth Powered by Tech Innovation & Rising Chronic Illness

The respiratory health landscape in Europe is undergoing a fundamental transformation — one propelled by rapidly rising chronic respiratory conditions, an aging demographic, technological leapfrog, and a healthcare system that increasingly favors patient-centric, home-based care.

According to Renub Research, the Europe Respiratory Care Devices Market which stood at US$ 6.8 billion in 2024, is projected to reach US$ 12.97 billion by 2033, registering a CAGR of 7.45% from 2025 to 2033. This growth story is not just about market expansion — it’s about reshaping how Europe breathes, heals, monitors, and manages respiratory health.

What Are Respiratory Care Devices — And Why Are They Important?

Respiratory care devices support patients with breathing complications resulting from conditions like Asthma, COPD (Chronic Obstructive Pulmonary Disease), Sleep Apnea, Respiratory Distress Syndrome, and Cystic Fibrosis. These devices are instrumental in diagnosing, monitoring, delivering therapy, and improving quality of life.

Some of the most widely used devices include:

Ventilators

Nebulizers & Inhalers

Oxygen Concentrators

CPAP & BiPAP Machines

Pulse Oximeters

Spirometers

Portable Homecare Respiratory Equipment

Historically restricted to hospitals and clinical settings, respiratory treatment is increasingly shifting to home environments, driven by compact device designs, remote connectivity, and patient-friendly diagnostic tools.

Market Growth Drivers: Why Europe Is Leading This Surge

1. Surging Respiratory Disease Burden

Europe is reporting a steady rise in respiratory conditions influenced by air pollution, rising smoking habits in urban zones, changing lifestyles, and declining lung health among older populations.

In Germany, asthma affects nearly 10% of children and 4–5% of adults

France recorded 13.5% asthma prevalence, one of the highest in Europe

COPD and sleep apnea cases continue to grow rapidly across Central and Western Europe

This intensifying disease prevalence is accelerating demand for diagnostic, monitoring, and therapeutic respiratory devices, including CPAPs, nebulizers, and oxygen concentrators.

2. Medical Tech Innovation & Smart Respiratory Devices

The industry is evolving beyond standard machines toward connected, AI-enabled, and smart respiratory care systems.

For instance:

In March 2022, UK-based MAGNET GROUP partnered with KoKo, LLC to enhance spirometry solutions using advanced lung function diagnostic software.

Development of AI-enabled ventilators, digital inhalers, and telemonitoring platforms allows predictive diagnosis, automated breathing calibration, and real-time medical assistance.

These breakthroughs enable better patient compliance, smarter treatment models, reduced hospitalization, and improved mortality outcomes.

3. Growing 65+ Population Across Europe

Europe has one of the fastest-aging populations worldwide:

21.6% of the EU population (449.3 million) was 65+ as of January 2024 – European Commission

As lung function declines naturally with age, vulnerability to COPD, pulmonary infections, asthma, and sleep apnea increases. This fuels the need for portable oxygen systems, CPAPs, home ventilators, and respiratory diagnostics.

4. Expansion of Home Healthcare Services

Homecare adoption has surged due to:

Rising hospital costs

Increased patient preference for home treatment

Portable and wearable respiratory devices

Post-pandemic work-from-home culture aligning with home-based patient care

Remote monitoring platforms and telemedicine integration have made respiratory care efficient, accessible, and independent of clinical environments.

Challenges Hindering Market Adoption

1. High Device and Maintenance Costs

Advanced medical devices such as CPAP, ventilators, and portable oxygen concentrators come with high upfront and recurring costs. This financial barrier impacts adoption, especially in:

Low-income patient groups

Public healthcare systems under budget pressure

Elderly patients on fixed pensions

2. Complex Regulatory Framework

The EU Medical Device Regulation (MDR) has made approvals stricter, requiring enhanced:

Clinical validation

Post-market monitoring

Safety compliance

While beneficial for patient safety, these regulations cause higher compliance costs, delayed approvals, and limited market entry for smaller manufacturers.

Country-Wise Market Highlights

🇩🇪 Germany

One of Europe’s fastest-growing respiratory care markets

High incidence of asthma, COPD, and sleep apnea

Strong adoption of digital and wearable respiratory diagnostics

In March 2022, researchers from FAU (Germany) and McGill University received EUR 225,000 funding to build a wearable device that monitors chronic respiratory conditions — reflecting Germany’s leadership in respiratory innovation.

🇫🇷 France

Holds one of the highest asthma prevalence rates (13.5%)

Strong demand for nebulizers, oxygen concentrators, and inhalation therapy

Growing shift toward portable home respiratory equipment

Strong hospital infrastructure driving advanced adoption

🇬🇧 United Kingdom

Rapidly adopting respiratory devices due to aging demographics

Strong penetration of homecare respiratory equipment

Technology-led initiatives shaping the ecosystem

Recent developments include:

Honeywell, May 2022 – launched NIOSH-certified respiratory masks, including smaller-fit N95 respirators

Responsive Respiratory, Jan 2022 – launched a new portfolio including Purify O3 Elite Sanitizer for oxygen and PAP accessories

Market Segmentation Summary

By Device Type

Therapeutic Devices

Monitoring Devices

Diagnostic Devices

Consumables & Accessories

By Product Type

Respiratory Consumables

Nebulizers

Oxygen Concentrators

Polysomnography Devices

Pulse Oximeters

Mechanical Ventilators

Spirometers

Others

By Application

COPD

Obstructive Sleep Apnea

Asthma

Respiratory Distress Syndrome

Cystic Fibrosis

Others

By End Users

Hospitals

Homecare

Ambulatory Care

By Country

France, Germany, Italy, Spain, UK, Belgium, Netherlands, Russia, Poland, Greece, Portugal, Norway, Romania, Rest of Europe

Competitive Landscape: Key Industry Leaders

Major companies transforming respiratory healthcare include:

Medtronic Plc

Koninklijke Philips

General Electric Company

Masimo Corporation

ResMed Inc

Becton, Dickinson and Company

Chart Industries Inc

Getinge AB

These companies focus on remote monitoring ecosystems, portable respiratory devices, AI-powered ventilators, homecare innovations, and strategic collaborations.

Future Outlook: What’s Next for Europe?

The next decade will revolve around:

✔ AI-powered breathing assistance and analytics

✔ Real-time remote patient monitoring

✔ Ultra-portable medical oxygen devices

✔ Smart inhalers connected to cloud platforms

✔ Explosion of home-based respiratory care services

✔ Strong growth in COPD and sleep apnea diagnostic tech

Final Thoughts

Europe stands at a pivotal moment in respiratory healthcare evolution. With aging populations, increased lung disease prevalence, home healthcare adoption, and rapid device innovation, the market is positioned for substantial expansion — not only in revenue but also in patient empowerment, life expectancy, and medical accessibility.

The respiratory care shift in Europe is clear: from hospital-centric treatment to patient-centric living.

Healthcare is no longer just about surviving respiratory disease — it’s about breathing better, living longer, and monitoring smarter.